Effect of Ivermectin on induction of apoptosisin human keratinocyte cell line (HaCaT)

سال انتشار: 1402
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 51

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

CGC01_241

تاریخ نمایه سازی: 29 آبان 1402

چکیده مقاله:

Objectives: Cancer is one of the most common complicationsin the world and cutaneous squamous cell carcinoma (cSCC) isamong the most prevalent cancers. Most cSCCs can be treatedby surgery, but we need other treatments for few resistant cases.HaCaT is a popular cell line for skin cancer studies. The aim ofthe present study was to investigate the effect of different dosesof ivermectin on the cell viability of HaCaT cancer cells.Materials and Methods: HaCaT cells were cultured in DMEMmedium containing ۱۰% FBS and treated with ۰.۲, ۰.۴, ۰.۸, ۱.۵,and ۸ μM concentration of ivermectin and then ۷۲ hours laterwere evaluated by MTT assay for their viability. The morphologyof the cells was also examined by Giemsa staining usinginvert microscopy. Also, the expression of Bax, Bad, BCL-۲genes was evaluated via Real-Time PCR. Data were analyzedusing SPSS version ۲۵.Results: Using MTT assay, IC۵۰ of ivermectin on HaCaT cellswere determined to be ۱.۵ μM. ۰.۲ and ۸ μM had the lowest andhighest apoptotic effect on HaCaT cells. PCR results showedelevated Bax and Bad and reduced BCL-۲ gene expression.Conclusion: Ivermectin was able to exert a good killing and apoptoticeffects on cancer cells. Therefore, ivermectin can probablybe used as an anticancer agent in modern cSCC therapies.

کلیدواژه ها:

نویسندگان

Mohammad Hossein Gholami

Faculty of Veterinary Medicine, Kazerun Branch, Islamic AzadUniversity, Kazerun, Iran

Sepideh Mirzaei

Department of Biology, Faculty of Science, Islamic Azad University,Science and Research Branch, Tehran, Iran

Negin Esfandiari

Department of Food Hygiene and Quality Control, Division ofEpidemiology, Faculty of Veterinary Medicine, University of Tehran,Tehran, Iran.